Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R

Table 1 Clinicopathological characteristics of miR-133a

Categories	Patients, n	Mean expression of miR-133a (mean ± SEM)	P value
Sex
Male	63	1.30 ± 0.21	0.47
Female	42	1.08 ± 0.19
Age (yr)
≥ 60	57	1.30 ± 0.21	0.52
< 60	48	1.11 ± 0.20
Diameter (cm)
≥ 5	39	1.09 ± 0.30	0.52
< 5	66	1.29 ± 0.16
Location
Middle and proximal third	69	1.22 ± 0.20	0.95
Distal third	36	1.20 ± 0.21
Degree of differentiation
Well and moderately	36	1.71 ± 0.29	0.01
Poorly	69	0.96 ± 0.14
Local invasion
T1+T2	30	1.89 ± 0.32	0.001
T3+T4	75	0.95 ± 0.13
Lymph node metastasis
No	42	1.53 ± 0.28	0.07
Yes	63	1.0 ± 0.15
TNM stage
I + II	36	1.68 ± 0.30	0.02
III + IV	69	0.97 ± 0.14